BioAdaptives, Inc.
BDPT
$0.02
$0.007.83%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 43.75% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 43.75% | -- | |||
| Cost of Revenue | -63.64% | -- | |||
| Gross Profit | 254.55% | -- | |||
| SG&A Expenses | -4.05% | 12.12% | |||
| Depreciation & Amortization | 50.00% | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.28% | 13.37% | |||
| Operating Income | 4.84% | -12.08% | |||
| Income Before Tax | -140.34% | 19.89% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -140.34% | 19.89% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -140.34% | 19.89% | |||
| EBIT | 4.84% | -12.08% | |||
| EBITDA | 5.20% | -12.06% | |||
| EPS Basic | -123.49% | 23.85% | |||
| Normalized Basic EPS | -182.69% | 23.53% | |||
| EPS Diluted | -123.49% | 23.85% | |||
| Normalized Diluted EPS | -182.69% | 23.53% | |||
| Average Basic Shares Outstanding | 7.40% | 5.36% | |||
| Average Diluted Shares Outstanding | 7.40% | 5.36% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||